Please enable JavaScript to continue using this application.

Compare $SION vs $TRDA | Chartloom

Compare

$SION vs $TRDA

Sionna Therapeutics Inc · Entrada Therapeutics Inc

SION

Sionna Therapeutics Inc

TRDA

Entrada Therapeutics Inc

Compare $SION vs $TRDA

Comparing Sionna Therapeutics Inc and Entrada Therapeutics Inc

SIONSionna Therapeutics Inc

TRDAEntrada Therapeutics Inc

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

TRDAEntrada Therapeutics Inc

Market cap

$220M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.15x

Rev growth (TTM)

-94.1%

YTD performance

-43.6%

52W performance

-8.0%

FCF yield

-61.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SION

TRDA

Detailed metrics comparison

SION

Sionna Therapeutics Inc

TRDA

Entrada Therapeutics Inc

Market Cap

SION$221M

TRDA$220M

Enterprise Value

SION$158M

TRDA$121M

Price

SION$4.90

TRDA$5.67

P/E Ratio

SIONN/A

TRDAN/A

P/S Ratio

SION0.00x

TRDA46.97x

EV/Sales

SION0.00x

TRDA25.79x

EV/EBITDA

SION0.00x

TRDA15.47x

P/B Ratio

SION0.84x

TRDA0.90x

P/FCF Ratio

SIONN/A

TRDAN/A

EV/FCF

SION-2.07x

TRDA-0.89x

PEG Ratio

SIONN/A

TRDAN/A

Forward P/E (NTM)

SIONN/A

TRDAN/A

Forward P/S (NTM)

SIONN/A

TRDA5.15x

Revenue (TTM)

SION$0

TRDA$5M

Revenue Growth (YoY)

SIONN/A

TRDA-94.1%

Forward Rev Growth

SION1297.1%

TRDA124.9%

Gross Margin (TTM)

SION0.0%

TRDA0.0%

Operating Margin (TTM)

SION0.0%

TRDA0.0%

EBITDA Margin (TTM)

SION0.0%

TRDA-3686.8%

Net Margin (TTM)

SION0.0%

TRDA-3537.7%

FCF Margin (TTM)

SIONN/A

TRDA-2883.2%

Net Income (TTM)

SION$-97M

TRDA$-166M

FCF (TTM)

SION$-76M

TRDA$-135M

EPS (TTM)

SION-$2.16

TRDA-$3.93

ROE (TTM)

SION-3294.0%

TRDA-5761.0%

ROA (TTM)

SION-3108.0%

TRDA-4654.0%

ROIC (TTM)

SION-3294.0%

TRDA-5761.0%

Cash

SION$63M

TRDA$99M

Debt

SION$0

TRDA$0

Net Cash/Debt

SION$63M

TRDA$99M

Current Ratio (TTM)

SION20.05x

TRDA10.89x

Quick Ratio (TTM)

SION19.57x

TRDA10.47x

Debt/Equity (TTM)

SION0.00x

TRDA0.00x

Debt/Assets (TTM)

SION0.0%

TRDA0.0%

Interest Coverage (TTM)

SIONN/A

TRDAN/A

Net Debt/EBITDA (TTM)

SION0.00x

TRDA0.00x

Beta

SION1.44

TRDA-0.22

52W Performance

SION-82.8%

TRDA-8.0%

YTD Performance

SION-87.5%

TRDA-43.6%

% from 52W High

SION-91.1%

TRDA-65.5%

% from 52W Low

SION22.2%

TRDA10.1%

Asset Turnover (TTM)

SION0.00x

TRDA0.01x

FCF Yield (TTM)

SION-34.4%

TRDA-61.4%

Earnings Yield (TTM)

SION-44.0%

TRDA-75.3%

Dividend Yield (TTM)

SIONN/A

TRDAN/A

Rule of 40

SION0.0

TRDA-2,977.3

EV/GP/RG

SIONN/A

TRDAN/A

Ticker research

View SION research View TRDA research

Metric	SION Sionna Therapeutics Inc	TRDA Entrada Therapeutics Inc
Market & Valuation
Market Cap	$221M	$220M
Enterprise Value	$158M	$121M
Price	$4.90	$5.67
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	46.97x
EV/Sales	0.00x	25.79x
EV/EBITDA	0.00x	15.47x
P/B Ratio	0.84x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.07x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.15x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	-94.1%
Forward Rev Growth	1297.1%	124.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3686.8%
Net Margin (TTM)	0.0%	-3537.7%
FCF Margin (TTM)	N/A	-2883.2%
Net Income (TTM)	$-97M	$-166M
FCF (TTM)	$-76M	$-135M
EPS (TTM)	-$2.16	-$3.93
ROE (TTM)	-3294.0%	-5761.0%
ROA (TTM)	-3108.0%	-4654.0%
ROIC (TTM)	-3294.0%	-5761.0%
Financial Health
Cash	$63M	$99M
Debt	$0	$0
Net Cash/Debt	$63M	$99M
Current Ratio (TTM)	20.05x	10.89x
Quick Ratio (TTM)	19.57x	10.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	-0.22
52W Performance	-82.8%	-8.0%
YTD Performance	-87.5%	-43.6%
% from 52W High	-91.1%	-65.5%
% from 52W Low	22.2%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-34.4%	-61.4%
Earnings Yield (TTM)	-44.0%	-75.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,977.3
EV/GP/RG	N/A	N/A
Ticker research	View SION research	View TRDA research

Valuation

P/S Ratio

SION

0.00x

TRDA

46.97x

EV/FCF

SION

-2.07x

TRDA

-0.89x

Growth & revenue

Revenue Growth TTM

TRDA

-94.1%

Forward Revenue Growth

SION

1297.1%

TRDA

124.9%

Profitability & performance

Gross Margin

SION

0.0%

TRDA

0.0%

ROE

SION

-3294.0%

TRDA

-5761.0%

FCF Yield %

SION

-34.4%

TRDA

-61.4%

52-Week Performance

TRDA

-8.0%

SION

-82.8%

Detailed metrics comparison

SION

Sionna Therapeutics Inc

TRDA

Entrada Therapeutics Inc

Market Cap

SION$221M

TRDA$220M

Enterprise Value

SION$158M

TRDA$121M

Price

SION$4.90

TRDA$5.67

P/E Ratio

SIONN/A

TRDAN/A

P/S Ratio

SION0.00x

TRDA46.97x

EV/Sales

SION0.00x

TRDA25.79x

EV/EBITDA

SION0.00x

TRDA15.47x

P/B Ratio

SION0.84x

TRDA0.90x

P/FCF Ratio

SIONN/A

TRDAN/A

EV/FCF

SION-2.07x

TRDA-0.89x

PEG Ratio

SIONN/A

TRDAN/A

Forward P/E (NTM)

SIONN/A

TRDAN/A

Forward P/S (NTM)

SIONN/A

TRDA5.15x

Revenue (TTM)

SION$0

TRDA$5M

Revenue Growth (YoY)

SIONN/A

TRDA-94.1%

Forward Rev Growth

SION1297.1%

TRDA124.9%

Gross Margin (TTM)

SION0.0%

TRDA0.0%

Operating Margin (TTM)

SION0.0%

TRDA0.0%

EBITDA Margin (TTM)

SION0.0%

TRDA-3686.8%

Net Margin (TTM)

SION0.0%

TRDA-3537.7%

FCF Margin (TTM)

SIONN/A

TRDA-2883.2%

Net Income (TTM)

SION$-97M

TRDA$-166M

FCF (TTM)

SION$-76M

TRDA$-135M

EPS (TTM)

SION-$2.16

TRDA-$3.93

ROE (TTM)

SION-3294.0%

TRDA-5761.0%

ROA (TTM)

SION-3108.0%

TRDA-4654.0%

ROIC (TTM)

SION-3294.0%

TRDA-5761.0%

Cash

SION$63M

TRDA$99M

Debt

SION$0

TRDA$0

Net Cash/Debt

SION$63M

TRDA$99M

Current Ratio (TTM)

SION20.05x

TRDA10.89x

Quick Ratio (TTM)

SION19.57x

TRDA10.47x

Debt/Equity (TTM)

SION0.00x

TRDA0.00x

Debt/Assets (TTM)

SION0.0%

TRDA0.0%

Interest Coverage (TTM)

SIONN/A

TRDAN/A

Net Debt/EBITDA (TTM)

SION0.00x

TRDA0.00x

Beta

SION1.44

TRDA-0.22

52W Performance

SION-82.8%

TRDA-8.0%

YTD Performance

SION-87.5%

TRDA-43.6%

% from 52W High

SION-91.1%

TRDA-65.5%

% from 52W Low

SION22.2%

TRDA10.1%

Asset Turnover (TTM)

SION0.00x

TRDA0.01x

FCF Yield (TTM)

SION-34.4%

TRDA-61.4%

Earnings Yield (TTM)

SION-44.0%

TRDA-75.3%

Dividend Yield (TTM)

SIONN/A

TRDAN/A

Rule of 40

SION0.0

TRDA-2,977.3

EV/GP/RG

SIONN/A

TRDAN/A

Ticker research

View SION research View TRDA research

Metric	SION Sionna Therapeutics Inc	TRDA Entrada Therapeutics Inc
Market & Valuation
Market Cap	$221M	$220M
Enterprise Value	$158M	$121M
Price	$4.90	$5.67
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	46.97x
EV/Sales	0.00x	25.79x
EV/EBITDA	0.00x	15.47x
P/B Ratio	0.84x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.07x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.15x
Revenue & Growth
Revenue (TTM)	$0	$5M
Revenue Growth (YoY)	N/A	-94.1%
Forward Rev Growth	1297.1%	124.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3686.8%
Net Margin (TTM)	0.0%	-3537.7%
FCF Margin (TTM)	N/A	-2883.2%
Net Income (TTM)	$-97M	$-166M
FCF (TTM)	$-76M	$-135M
EPS (TTM)	-$2.16	-$3.93
ROE (TTM)	-3294.0%	-5761.0%
ROA (TTM)	-3108.0%	-4654.0%
ROIC (TTM)	-3294.0%	-5761.0%
Financial Health
Cash	$63M	$99M
Debt	$0	$0
Net Cash/Debt	$63M	$99M
Current Ratio (TTM)	20.05x	10.89x
Quick Ratio (TTM)	19.57x	10.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	-0.22
52W Performance	-82.8%	-8.0%
YTD Performance	-87.5%	-43.6%
% from 52W High	-91.1%	-65.5%
% from 52W Low	22.2%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-34.4%	-61.4%
Earnings Yield (TTM)	-44.0%	-75.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,977.3
EV/GP/RG	N/A	N/A
Ticker research	View SION research	View TRDA research